KIM LLC’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-16,666
Closed -$4K – 655
2022
Q4
$4K Hold
16,666
– – ﹤0.01% 551
2022
Q3
$1K Hold
16,666
– – ﹤0.01% 824
2022
Q2
$2K Buy
+16,666
New +$2.82K ﹤0.01% 847

KIM LLC's EBACW Position: Q1 2023 in Review

KIM LLC sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 16,666 shares — an estimated $4K sold.

KIM LLC first reported a position in EBACW in Q2 2022 and held it in 3 quarters. The position peaked at $4K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • KIM LLC reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • KIM LLC sold 16,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $4K.
  • KIM LLC first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2022 and held it in 3 quarters.
  • KIM LLC's European Biotech Acquisition Corp. Warrant position peaked at $4K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on KIM LLC's 13F filing for Q1 2023, filed 11 May 2023.